MUSCULOSKELETAL DISEASE
Clinical trials for MUSCULOSKELETAL DISEASE explained in plain language.
Never miss a new study
Get alerted when new MUSCULOSKELETAL DISEASE trials appear
Sign up with your email to follow new studies for MUSCULOSKELETAL DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Hope for slowing muscle loss in duchenne muscular dystrophy
Disease control CompletedThis study tested whether a drug called ataluren could slow the progression of muscle weakness in boys with a specific genetic form of Duchenne muscular dystrophy. For 72 weeks, 360 participants received either ataluren or a placebo, followed by another 72 weeks where everyone re…
Matched conditions: MUSCULOSKELETAL DISEASE
Phase: PHASE3 • Sponsor: PTC Therapeutics • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC
-
New scans could predict which arthritis knees will worsen
Knowledge-focused CompletedThis study tested whether advanced imaging techniques could predict which patients with knee osteoarthritis would experience worsening joint damage over three years. Researchers followed 167 people with painful knee arthritis, using special X-rays and MRI scans to analyze bone te…
Matched conditions: MUSCULOSKELETAL DISEASE
Phase: NA • Sponsor: Centre Hospitalier Régional d'Orléans • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC
-
New tool aims to predict who needs help at home after hospital
Knowledge-focused CompletedThis study tested a Turkish version of a questionnaire called the Johns Hopkins In-Room Independence Scale. Researchers gave the questionnaire to 100 adult volunteers with various conditions to see if it reliably measures how well a person can move and care for themselves in thei…
Matched conditions: MUSCULOSKELETAL DISEASE
Sponsor: Sisli Hamidiye Etfal Training and Research Hospital • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC